Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
6.12
+0.01 (0.16%)
Nov 22, 2024, 4:00 PM EST - Market closed
Pulmatrix Market Cap
Pulmatrix has a market cap or net worth of $22.35 million as of November 22, 2024. Its market cap has increased by 223.94% in one year.
Market Cap
22.35M
Enterprise Value
11.57M
1-Year Change
223.94%
Ranking
Category
Stock Price
$6.12
Market Cap Chart
Since March 21, 2014, Pulmatrix's market cap has decreased from $30.40M to $22.35M, a decrease of -26.47%. That is a compound annual growth rate of -2.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 20.50M | 201.47% |
| Dec 29, 2023 | 6.80M | -51.77% |
| Dec 30, 2022 | 14.10M | -42.68% |
| Dec 31, 2021 | 24.60M | -39.85% |
| Dec 31, 2020 | 40.90M | 137.79% |
| Dec 31, 2019 | 17.20M | 52.21% |
| Dec 31, 2018 | 11.30M | -61.95% |
| Dec 29, 2017 | 29.70M | 241.38% |
| Dec 30, 2016 | 8.70M | -85.74% |
| Dec 31, 2015 | 61.00M | 263.10% |
| Dec 31, 2014 | 16.80M | -44.74% |
| Mar 21, 2014 | 30.40M | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Femasys | 23.34M |
| IN8bio | 23.02M |
| Movano | 22.82M |
| VSee Health | 22.74M |
| Cocrystal Pharma | 22.38M |
| Pieris Pharmaceuticals | 22.21M |
| Bolt Biotherapeutics | 22.14M |
| XTL Biopharmaceuticals | 21.94M |